ArticleChinese medicine2022

Ludangshen oral liquid for treatment of convalescent COVID-19 patients: a randomized, double-blind, placebo-controlled multicenter trial.

Xuedong An et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.